Thoracic Complications in Supracostal Percutaneous Nephrolithotomy.


Journal

Journal of Nepal Health Research Council
ISSN: 1999-6217
Titre abrégé: J Nepal Health Res Counc
Pays: Nepal
ID NLM: 101292936

Informations de publication

Date de publication:
02 Nov 2022
Historique:
received: 20 11 2021
accepted: 02 11 2022
entrez: 23 12 2022
pubmed: 24 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Due to the risk of pleural injury leading to thoracic complications, many urologist still hesitate to perform supracostal puncture during percutaneous nephrolithotomy. Our aim of this study was to evaluate the thoracic complications in supracostal access percutaneous nephrolithotomy. This is a retrospective analysis of 101 patients who were treated with supracostal access percutaneous nephrolithotomy at our institute from September 2013 and December 2019. Indications for supracostal punctures were staghorn 28(27.7%), middle calyceal stones 10(9.9%), pelvic stones 29(28.7%), complex inferior calyceal stones 26(25.7%), upper calyceal stone 10(9.9%)and upper ureteric stone17(16.8%).The intercostal space between the 11th and 12th ribs was used in all the cases. Among the 101 patients who undergone percutaneous nephrolithotomy by supracostal access, three patients (2.97%) had pleural injury. Among them one patient developed hydrothorax and needed chest tube insertion and remaining two patients had minimal pneumo thorax with blunting of costo-phrenic angle, which was managed conservatively. The lung parenchymal or other viscera injury was not observed in our study. Most punctures were, a single supracostal superior calyceal access 18(17.8%) and middle posterior calyceal access 88(82.2%), except for staghorn and multiple complex lower calyceal calculi needed multiple tracts 23(22.8%). Complete clearance was observed in 77(76.2%) patients. The supracostal puncture was a safe and effective approach with high stone clearance rate and acceptable morbidity in selected cases of staghorn, upper ureteral, and upper calyceal calculi. It should be adapted whenever needed and should not be avoided due to fear of chest complications.

Sections du résumé

BACKGROUND BACKGROUND
Due to the risk of pleural injury leading to thoracic complications, many urologist still hesitate to perform supracostal puncture during percutaneous nephrolithotomy. Our aim of this study was to evaluate the thoracic complications in supracostal access percutaneous nephrolithotomy.
METHODS METHODS
This is a retrospective analysis of 101 patients who were treated with supracostal access percutaneous nephrolithotomy at our institute from September 2013 and December 2019. Indications for supracostal punctures were staghorn 28(27.7%), middle calyceal stones 10(9.9%), pelvic stones 29(28.7%), complex inferior calyceal stones 26(25.7%), upper calyceal stone 10(9.9%)and upper ureteric stone17(16.8%).The intercostal space between the 11th and 12th ribs was used in all the cases.
RESULTS RESULTS
Among the 101 patients who undergone percutaneous nephrolithotomy by supracostal access, three patients (2.97%) had pleural injury. Among them one patient developed hydrothorax and needed chest tube insertion and remaining two patients had minimal pneumo thorax with blunting of costo-phrenic angle, which was managed conservatively. The lung parenchymal or other viscera injury was not observed in our study. Most punctures were, a single supracostal superior calyceal access 18(17.8%) and middle posterior calyceal access 88(82.2%), except for staghorn and multiple complex lower calyceal calculi needed multiple tracts 23(22.8%). Complete clearance was observed in 77(76.2%) patients.
CONCLUSIONS CONCLUSIONS
The supracostal puncture was a safe and effective approach with high stone clearance rate and acceptable morbidity in selected cases of staghorn, upper ureteral, and upper calyceal calculi. It should be adapted whenever needed and should not be avoided due to fear of chest complications.

Identifiants

pubmed: 36550713
doi: 10.33314/jnhrc.v20i02.3950
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

361-365

Auteurs

Ashok Kumar Kunwar (AK)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Amit Mani Upadhyaya (AM)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Kabir Tiwari (K)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Sanjesh Bhakta Shrestha (SB)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Chandra Shekhar Yadav (CS)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Bikkin Dangol (B)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Parash Mani Shrestha (PM)

Department of general surgery,phect-Nepal,Kathmandu Model Hospital, 2National Academy of Health Science NAMS, Bir Hospital, Kathmandu, Nepal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH